Olakino 400 Tablet contains Ademetionine 400 mg, a naturally occurring compound involved in methylation processes essential for cellular function and liver health. Ademetionine plays a critical role in the synthesis of neurotransmitters, phospholipids, and glutathione, contributing to its hepatoprotective, antidepressant, and anti-inflammatory properties. Olakino 400 is primarily indicated for the treatment of liver disorders such as cholestasis, cirrhosis, and chronic hepatitis, where it aids in restoring normal liver function by enhancing membrane fluidity and promoting detoxification. Additionally, it is utilized as an adjunct therapy in depressive disorders due to its influence on neurotransmitter metabolism, improving mood and cognitive function. The tablet is administered orally, with dosage tailored according to the severity of the condition and patient response, under medical supervision. Ademetionine is generally well tolerated; however, potential side effects may include gastrointestinal disturbances, headache, or allergic reactions. Caution is advised in patients with bipolar disorder or those on antidepressant therapy to avoid serotonin syndrome. Olakino 400 should be used as part of a comprehensive treatment plan, including lifestyle modifications and monitoring of liver function tests to ensure optimal therapeutic outcomes.